Overview
Trajenta Tablets 5 mg contain Linagliptin, an oral antidiabetic medication from the class of DPP-4 (dipeptidyl peptidase-4) inhibitors. It is prescribed to improve glycemic control in adults with type 2 diabetes mellitus. Linagliptin enhances the body’s natural ability to regulate blood glucose by increasing the levels of incretin hormones, which stimulate insulin release and suppress glucagon secretion after meals.





